Viewing Study NCT05836103



Ignite Creation Date: 2024-05-06 @ 6:56 PM
Last Modification Date: 2024-10-26 @ 2:57 PM
Study NCT ID: NCT05836103
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-07-12
First Post: 2023-04-18

Brief Title: Testing the Impact of Smartphone-based Messaging to Support Young Adult Smoking Cessation
Sponsor: Johns Hopkins Bloomberg School of Public Health
Organization: Johns Hopkins Bloomberg School of Public Health

Study Overview

Official Title: Testing the Impact of Smartphone-based Messaging to Support Young Adult Smoking Cessation
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Clinical practice guidelines for smoking cessation emphasize cognitive behavioral therapy CBT to help patients develop coping strategies for urges Mindfulness or Acceptance and Commitment Therapy ACT offer a different approach which teaches smokers psychological flexibility through accepting negative experiences While there is evidence for the efficacy of both CBT and MindfulnessACT smoking cessation interventions it is unclear if these approaches are efficacious when implemented in real-time and with young adults The overall goal of this proposal is to evaluate the efficacy of CBT and MindfulnessACT messages for young adults targeted at specific high-risk situations for smoking
Detailed Description: This research will address the following specific aims

Aim 1 To test CBT and MindfulnessACT intervention message efficacy for reducing momentary smoking urges N80 To inform just-in-time interventions it is crucial to test if CBT and MindfulnessACT based messages can reduce momentary smoking urges The investigators will conduct a micro-randomized trial repeated within-subject randomizations of messages to accomplish this In line with the investigators existing protocol participants first collect Ecological Momentary Assessment EMA data for 14 days allowing the investigators to determine high-risk situations for smoking In the following intervention phase participants receive tailored messages triggered by geofencing of participants high-risk locations for a total of 30 days Tailoring is based on established predictors of smoking relapse stress and presence of other smokers The micro-randomized trial tests the efficacy of CBT versus MindfulnessACT versus control messages for reducing smoking urge 15 minutes post message delivery Secondary outcomes include smoking or other tobacco use including e-cigarettes affect and stress

Aim 2 To test if exposure to urge reduction messages results in changes in smoking behavior over time compared to an EMA only control group N80 It is important to investigate if repeated messages in the micro-randomized trial impact smoking behavior over time in contrast to just repeated assessment without messages Thus this study includes a conventionally randomized clinical-trial component Parallel to the micro-randomized trial group a control group completes EMA surveys only without intervention messages This allows the investigators to test if messages reduce smoking behavior The primary outcome is number of cigarettes per day at end of treatment 3- and 6-months follow-up Secondary analyses explore biochemically verified 7-day point prevalence abstinence switching to e-cigarettes and other tobacco outcomes Post-hoc dose-response analyses investigate the long-term efficacy of CBT or MindfulnessACT messages on smoking behavior

Aim 3 Explore moderation effects of substance co-use cannabis alcohol other drugs and exposure to specific location home work bars on urge reduction message efficacy A crucial research question to inform future mobile interventions is how well intervention messages work in different situational contexts and when people are co-using other substances Among intervention group participants the investigators will explore how urge reduction message efficacy may be moderated by substance co-use and exposure to specific settings

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None